经肝动脉化疗栓塞联合射频消融术和艾迪治疗原发性肝癌患者疗效及其对外周血T淋巴细胞亚群的影响*

doi:10.3969/j.issn.1672-5069.2018.02.026

摘要/Abstract

摘要： 目的探讨采用肝动脉化疗栓塞术（TACE）联合射频消融（RFA）和艾迪注射液治疗原发性肝癌（PLC）患者的疗效及其对外周血淋巴细胞亚群和炎性因子水平的影响。方法 2013年1月~2015年1月收治的76例PLC患者,其中36例接受TACE联合RFA和艾康治疗（观察组）,另40例接受TACE和RFA治疗（对照组）。采用酶联免疫吸附法测定血清C反应蛋白（CRP）、肿瘤坏死因子-α（TNF-α）和白介素-6（IL-6）水平,使用流式细胞仪测定外周血T细胞亚群。采用Karnofsky评分评估生存质量改善情况。结果在治疗后3 m末,观察组疾病缓解率为69.4%,与对照组的55.0%比,差异无统计学意义（P>0.05）,但观察组疾病控制率为91.7%,显著高于对照组的72.5%（P<0.05）;观察组血清CRP、TNF-α和IL-6水平分别为（109.8±13.2） mg/L、（0.5±0.2） pg/mL和（13.4±2.2） pg/mL,均显著低于对照组[（156.2±20.4） mg/L、（1.1±0.2） pg/mL和（24.1±4.4）pg/mL,P<0.05];外周血CD3+和CD4+细胞百分比及CD4+/CD8+比值分别为（60.1±9.7）%、（44.3±8.3）%和（1.9±0.5）,均显著高于对照组[（52.2±9.9）%、（36.30±8.6）%和（1.4±0.3）,P<0.05];观察组生存质量改善率为80.5%,显著高于对照组的57.5%（P<0.05）;随访24 m,观察组生存28例（77.8%）,对照组生存29例（72.5%）,差异无统计学意义（P>0.05）。结论采用TACE联合RFA和艾迪注射液治疗PLC患者近期可调节免疫功能,改善患者生活质量,有一定的临床应用价值。

关键词: 原发性肝癌, 肝动脉化疗栓塞术, 射频消融, 艾迪注射液, 治疗

Abstract: Objective To investigate the efficacy of transcatheter arterial chemoembolization（TACE） combined with radiofrequency ablation（RFA） and Addie injection in the treatment of patients with primary liver cancer（PLC）. Methods A total of 76 PLC patients were recruited in our hospital between January 2013 and January 2015,and they were divided into the observation group （n=36） and the control group （n=40）,receiving combination of TACE, RFA and Addie and TACE and RFA,respectively. Serum C-reactive protein （CRP）,tumor necrosis factor-α （TNF-α） and interleukin-6 （IL-6）,and peripheral blood lymphocyte subsets were assayed. The quality of life was evaluated by Karnofsky’s score. Results There were significant difference in the disease control rate between the observation and the control group（91.7% vs. 72.5%） at the end of 3 month after treatment （P<0.05）;serum CRP,TNF-α and IL-6 levels were （109.8±13.2） mg/L,（0.5±0.2） pg/mL and （13.4±2.2） pg/mL in the observation group,significantly lower than [（156.2±20.4） mg/L,（1.1±0.2） pg/mL and （24.1±4.4） pg/mL in the control,P<0.05];the percentages of peripheral blood CD3+ and CD4+ cells and ratio of CD4+/CD8+ cells were（60.1±9.7）%,（44.3±8.3）% and （1.9±0.5）,respectively,significantly higher than [（52.2±9.9）%,（36.30±8.6） % and （1.4±0.3） in the control,P<0.05];the improvement rate of quality of life was significantly higher than that in the control group （80.5% vs. 57.5%,P<0.05）;at the end of 24 month followed-up,28（77.8%） survived in the observation group,while 29（72.5%） survived in the control（P>0.05）. Conclusions Addie injection,a herbal compound,might improve the quality of life in PLC patients receiving TACE and RFA therapy,which might be related to the reduction of inflammatory reaction,and enhance immune functions.

Key words: Hepatoma, Transcatheter arterial chemoembolization, Radiofrequency ablation, Addie injection, a hebal compound, Therapy

刘大勇, 杨光华, 鲁朝敏. 经肝动脉化疗栓塞联合射频消融术和艾迪治疗原发性肝癌患者疗效及其对外周血T淋巴细胞亚群的影响*[J]. 实用肝脏病杂志, 2018, 21(2): 261-264.

Liu Dayong, Yang Guanghua, Lu Zhaomin. Efficacy of transcatheter arterial chemoembolization combined with radiofrequency ablation and Addie injection in the treatment of patients with primary liver cancer[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(2): 261-264.

参考文献

[1] 王鹤,董家鸿,卢实春,等. 手术切除与射频消融治疗原发性肝癌患者预后比较. 实用肝脏病杂志,2017,20(3):337-340.
[2] Li A,Ma S,Pawlik T,et al.Surgical treatment of double primary liver cancer:An observational study for a rare type of tumor.Medicine,2016,95(32):e4412.
[3] 潘国政,徐教邦,郝龙,等. 射频消融及肝动脉化疗栓塞术后杀伤细胞回输对肝癌患者预后的影响.中华医学杂志,2016,96(9):689-692.
[4] 周霞,刘鸿凌. 《2015年EASL肝移植临床实践指南》摘译. 实用肝脏病杂志,2016,19(9):385-388.
[5] Zanaboni F,Grijuela B,Giudici S,et al.Weekly topotecan and cisplatin(TOPOCIS) as neo-adjuvant chemotherapy for locally-advanced squamous cervical carcinoma:Results of a phase Ⅱ multicentricstudy. Eur J Cancer,2013,49(5):1065-1072.
[6] Pahwa A,Beckett K,Channual S,et al.Efficacy of the American Association for the Study of Liver Disease and Barcelona criteria for the diagnosis of hepatocellular carcinoma. Abdom Imaging,2014,39(4):753-760.
[7] Terret C,Albrand G,Moncenix G,et al.Karnofsky performance scale(KPS) or physical performance test(PPT) That is the question. Crit Rev Oncol Hemat,2011,77(2):142.
[8] ROC A,Valadao M,Borges D,et al.Nonoperative management of rectal cancer after chemoradiation opposed to resection after complete clinical response. A comparative study. Eur J Surg Oncol,2015,41(11):1456.
[9] Ikoma N,Rodriguez-Bigas MA.Managing the primary tumor with unresectable synchronous colorectal metastases. Curr Colorect Cancer Rep,2016,12(3):170-179.
[10] Suh SW,Choi YS.Predictors of micrometastases in patients with Barcelona clinic liver cancer classification B hepatocellular carcinoma. Yonsei Med J,2017,58(4):737.
[11] Veltri A,Guarnieri T,Gazzera C,et al.Long-term outcome of radiofrequency thermal ablation(RFA) of liver metastases from colorectal cancer (CRC):size as the leading prognostic factor for survival. Radiol Med,2012,117(7):1139-1151.
[12] Xu HX,Huang XE,LiY,et al. A clinical study on safety and efficacy of Aidi injection combined with chemotherapy. Asian Pac J Cancer P,2011,12(9):2233.
[13] Vogtmann E,Li HL,Shu XO,et al.Dietary glycemic load,glycemic index,and carbohydrates on the risk of primary liver cancer among Chinese women and men.Ann Oncol,2013,24(1):238-244.
[14] Zhang XQ,Zhou HY,Yang JC,et al.Assessment on the effectiveness and safety on carcinogenic pleural effusion treated with Aidi injection plus cisplatin. World J Integr Tradit West Med,2014,149(3):685-95.
[15] Park JS,Chang IT,Park SJ,et al.Comparison of ex vivo and in vivo injection of blue dye in sentinel lymph node mapping for colorectal cancer. World J Surg,2009,33(3):539-546.
[16] Jepsen RK,Ingeholm P,Lund EL.Upstaging of early colorectal cancers following improved lymph node yield after methylene blue injection. Histopathology,2012,61(5):788.
[17] Liberale G,Vankerckhove S,Caldon MG,et al.Fluorescence imaging after indocyanine green injection for detection of peritoneal metastases in patients undergoing cytoreductive surgery for peritoneal carcinomatosis from colorectal cancer:A pilot study. Ann Surg,2016,264(6):1110.
[18] 曹焱,姜峰,张超,等. 肝动脉栓塞化疗联合CT引导精准微波消融治疗原发性肝癌患者疗效及对外周血T淋巴细胞亚群的影响.实用肝脏病杂志,2017,20(4):468-471.
[19] Sileri P,Franceschilli L,Ciangola IC,et al.Mo1711 lymph-nodes harvest might be ameliorated by ex-vivo intra-arterial methylene blue dye injection after colorectal cancer surgery.Gastroenterology,2013,39(9):S54-S54.
[20] Wenhua M,Kainan D,Min F,et al.Aidi injection as an adjunct therapy for non-small cell lung cancer:a systematic review. Chin J Integr Med,2009,7(4):315.